BLI-489

DRUG4 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

HealthyHealthy Subjects

Phase 1

Study Evaluating Single Doses of BLI-489 in Healthy Subjects

CompletedNCT00820404

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects

Start: 2009-01-31End: 2009-04-30Updated: 2009-07-17

Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male Subjects

CompletedNCT00854009

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2009-02-20End: 2009-04-27Updated: 2018-09-27

Study Evaluating BLI-489 and Piperacillin in Healthy Subjects

CompletedNCT00894439

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects

Start: 2009-05-31End: 2009-07-31Updated: 2009-07-17

Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses

CompletedNCT00909688

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2009-06-05End: 2009-07-24Updated: 2018-09-27